Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 3623-3627, December 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Illiger, H.-J.
Right arrow Articles by Lindenmann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Illiger, H.-J.
Right arrow Articles by Lindenmann, J.

Replication of an Avian Myxovirus in Tumor Cell Cultures Obtained from Effusions of Mammary Carcinoma Patients1

Hans-Jochen Illiger2, Christian Sauter3 and Jean Lindenmann

Division of Oncology, Department of Medicine [H-J. I., C. S.], and Division of Experimental Microbiology, Institute of Medical Microbiology [J. L.], University of Zürich, 8091 Zürich, Switzerland

In view of the possible use of viruses for the immunotherapy of breast cancer, the replication of a strain of fowl plague virus was studied in the tumor cells of 11 mammary carcinoma patients with malignant effusions. The tumor cells were obtained by centrifugation on iodamide solutions, then cultured in vitro, and infected by a fowl plague virus previously adapted to grow in a mammary carcinoma cell line. Virus multiplication was observed in all cases, a prerequisite for the use of autologous viral oncolysates for immunotherapy in mammary carcinoma patients.

1 Supported by the Julius Müller Foundation for Cancer Research, Zürich, Switzerland; the Ludwig Institute for Cancer Research, Zürich Branch; and the Hans Gröber Stiftung, Vaduz, Liechtenstein.

2 Present address: Medizinische Universitätsklinik, Bonn, West Germary.

3 To whom requests for reprints should be addressed, at Division of Oncology, Department of Medicine, University of Zürich, 8091 Zürich, Switzerland.

Received 7/ 7/75. Accepted 8/26/75.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.